Trials - Closed

Multicenter, Prospective Evaluation of the Beckman Coulter DxN HCV Viral Load Assay as an aid in the Management of HCV-Infected Individuals Undergoing Antiviral Therapy

Open-Label Study To Evaluate The Efficacy, Safety, Tolerability and Pharmacokinetics of MN-001 (tipelukast) on HDL (High Density Lipoprotein) Function and Serum Triglyceride Levels in Non-Alcoholic Steatohepatitis (NASH) Subjects with Hypertriglyceridemia.

Clinical Evaluation of the Xpert® HCV VL Assay

Multicenter, Prospective Evaluation of the Beckman Coulter DxN HBV Viral Load Assay as an Aid in the Management of HBV-Infected Individuals Undergoing Antiviral Therapy

A Multicenter, Double-Blind, Sponsor-Open Trial of IDN-6556 in Subjects Who had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following anti-HCV Therapy

Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis (CLARITY)

Collection of Blood Specimens from Subjects Infected with Chronic Hepatitis C (Genotypes 2 and 3) and Treated with Sofosbuvir plus Ribavirin

A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072 (Champion2)

CTS-1027 in Interferon-Naive Hepatitis C Patients

Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders

Study of CTS-1027 in Hepatitis C Patients

Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)

AST-120 Used to Treat Mild Hepatic Encephalopathy (ASTUTE)

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy (AST015)

A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection

Retrospective Review of Baseline, On-Treatment, and Outcome Data for Patients in the United States Treated With Telaprevir After Marketing Approval

Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patient With Hepatic Insufficiency

Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)

Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis (SILVER)